HPLC-MS/MS investigation of biochemical markers for the disclosure of erythropoietin abuse in sports |
| |
Authors: | S A Appolonova M A Dikunets G M Rodchenkov |
| |
Institution: | (1) Federal Agency on Physical Culture and Sports, FGUP Antidoping Center, Moscow, Russia |
| |
Abstract: | The polypeptide hormone erythropoietin (EPO), which is a forbidden doping drug, was determined by high-performance liquid chromatography combined with tandem mass spectrometry (HPLC-MS/MS). The hypothesis about the influence of EPO on the asymmetric dimethylarginine (ADMA)-dimethylargininedime-thylaminohydrolase (DDAH)-NO-synthase system was verified. Changes in this system can serve as indirect biochemical markers of the presence of the forbidden EPO drug in the organism. In the test group, the concentrations of biochemical markers varied from 10 to 40 μg/ml for ADMA and symmetrical DMA (SDMA) and from 0.5 to 10 μg/ml for arginine and citrulline. A single intravenous administration of r-HuEPO (Epocrin, 2000 ME/day) for two volunteers reliably increased ADMA, SDMA, arginine, and citrulline concentrations to 40–270 μg/ml, 40–240μg/ml, 10–60 μg/ml, and 12–140 μg/ml, respectively, with respect to the reference values. The simultaneous increase in arginine, methylarginines, and citrulline contents could be an indirect marker of EPO abuse. The method is recommended for fast screening analysis. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|